Stereotaxis 的先进机器人心脏标测导管获得 FDA 批准，改善了心律失常治疗。 Stereotaxis receives FDA clearance for its advanced robotic heart mapping catheter, improving arrhythmia treatments.

Stereotaxis 的 MAGiC 扫描导管已获得 FDA 批准，这是世界上第一个机器人导航的高密度电生理学定位导管。 Stereotaxis has received FDA clearance for its MAGiC Sweep catheter, the world's first robotically navigated high-density electrophysiology mapping catheter. 通过这一进展,可以更高效、更详细、更准确地确定心律失常的起源,加强心脏衰减程序。 This advancement allows for more efficient, detailed, and precise identification of arrhythmia origins, enhancing cardiac ablation procedures. 该导管配有20个电极,提供延伸伸展、精确度和创伤设计,改善患者的治疗结果。 The catheter, equipped with 20 electrodes, offers extended reach, precision, and an atraumatic design, improving patient outcomes.